Characterization of Volatile Organic Compound Metabolites in Cigarette Smokers, Electronic Nicotine Device Users, Dual Users, and Nonusers of Tobacco

Nicotine and Tobacco Research

Volumn 22, Issue 2, 2020, Pages 264-272

  Keith, Rachel J ^a   Fetterman, Jessica L ^b   Orimoloye, Olusola A ^c   Dardari, Zeina ^c   Lorkiewicz, Pawel K ^a   Hamburg, Naomi M ^b   Defilippis, Andrew P ^a   Blaha, Michael J ^c   Bhatnagar, Aruni ^a  

^a University of Louisville School of Medicine   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; ACROLEIN; ACRYLAMIDE; ACRYLONITRILE; ALDEHYDE; ANABASINE; BENZENE; COTININE; CROTONALDEHYDE; ETHYLBENZENE; ETHYLENE OXIDE; N,N DIMETHYLFORMAMIDE; NICOTINE; PROPYLENE OXIDE; STYRENE; TOLUENE; VINYL CHLORIDE; VOLATILE ORGANIC COMPOUND; XYLENE; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; CIGARETTE SMOKING; FEMALE; HUMAN; MALE; MIDDLE AGED; NON-SMOKER; NORMAL HUMAN; PRIORITY JOURNAL; SELF REPORT; SEX RATIO; SMOKING HABIT; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; YOUNG ADULT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; ELECTRONIC CIGARETTE; METABOLISM; SMOKING; URINE; VAPING;

ADULT; BIOMARKERS; CIGARETTE SMOKING; COHORT STUDIES; COTININE; CROSS-SECTIONAL STUDIES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NON-SMOKERS; SMOKERS; VAPING; VOLATILE ORGANIC COMPOUNDS; YOUNG ADULT;

EID: 85079042338     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntz021     Document Type: Article

References (50)

1. Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res. 2008;10(12):1773-1782.
2. Haussmann HJ. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem Res Toxicol. 2012;25(4):794-810.
3. Jain RB. Distributions of selected urinary metabolites of volatile organic compounds by age, gender, race/ethnicity, and smoking status in a representative sample of U.S. adults. Environ Toxicol Pharmacol. 2015;40(2):471-479.
4. Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc Med. 2016;26(6):515-523.
5. Fifth Joint Task Force of the European Society of Cardiology, European Association of Echocardiography, European Association of Percutaneous Cardiovascular Interventions, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol. 2012;19(4):585-667.
6. Jung CC, Su HJ, Liang HH. Association between indoor air pollutant exposure and blood pressure and heart rate in subjects according to body mass index. Sci Total Environ. 2016;539:271-276.
7. Brito JM, Belotti L, Toledo AC, et al. Acute cardiovascular and inflammatory toxicity induced by inhalation of diesel and biodiesel exhaust particles. Toxicol Sci. 2010;116(1):67-78.
8. Wronska-Nofer T, Chojnowska-Jezierska J, Nofer JR, Halatek T, Wisniewska-Knypl J. Increased oxidative stress in subjects exposed to carbon disulfide (CS2)-an occupational coronary risk factor. Arch Toxicol. 2002;76(3):152-157.
9. Kotseva K. Occupational exposure to low concentrations of carbon disulfide as a risk factor for hypercholesterolaemia. Int Arch Occup Environ Health. 2001;74(1):38-42.
10. Seaton A, Godden D, MacNee W, Donaldson K. Particulate air pollution and acute health effects. Lancet. 1995;345(8943):176-178.
11. Rigotti NA. Balancing the benefits and harms of E-Cigarettes: a national academies of science, engineering, and medicine report. Ann Intern Med. 2018;168(9):666-667.
12. Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014;16(10):1319-1326.
13. Wang P, Chen W, Liao J, et al. A device-independent evaluation of carbonyl emissions from heated electronic cigarette solvents. PLoS One. 2017;12(1):e0169811.
14. Keith RJ, Fetterman JL, Riggs DW, et al. Protocol to assess the impact of tobacco-induced volatile organic compounds on cardiovascular risk in a cross-sectional cohort: Cardiovascular Injury due to Tobacco Use study. BMJ Open. 2018;8(3):e019850.
15. Parsons VL, Moriarity C, Jonas K, Moore TF, Davis KE, Tompkins L. Design and estimation for the national health interview survey, 2006-2015. Vital Health Stat 2. 2014;(165):1-53.
16. Wall MA, Johnson J, Jacob P, Benowitz NL. Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health. 1988;78(6):699-701.
17. Kasza KA, Ambrose BK, Conway KP, et al. Tobacco-product use by adults and youths in the United States in 2013 and 2014. N Engl J Med. 2017;376(4):342-353.
18. Osibogun O, Taleb ZB, Bahelah R, Salloum RG, Maziak W. Correlates of poly-tobacco use among youth and young adults: findings from the population assessment of tobacco and health study, 2013-2014. Drug Alcohol Depend. 2018;187:160-164.
19. Alwis KU, Blount BC, Britt AS, Patel D, Ashley DL. Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal Chim Acta. 2012;750:152-160.
20. Lorkiewicz P, Riggs DW, Keith RJ, et al. Comparison of urinary biomarkers of exposure in humans using electronic cigarettes, combustible cigarettes, and smokeless tobacco. Nicotine Tob Res. 2019:21(9):1228-1238.
21. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139.
22. Shahab L, Goniewicz ML, Blount BC, et al. Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann Intern Med. 2017;166(6):390-400.
23. Lee MS, LeBouf RF, Son YS, Koutrakis P, Christiani DC. Nicotine, aerosol particles, carbonyls and volatile organic compounds in tobacco-and menthol-flavored e-cigarettes. Environ Health. 2017;16(1):42.
24. Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P III, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine Tob Res. 2017;19(2):160-167.
25. Roemer E, Schorp MK, Piade JJ, Seeman JI, Leyden DE, Haussmann HJ. Scientific assessment of the use of sugars as cigarette tobacco ingredients: a review of published and other publicly available studies. Crit Rev Toxicol. 2012;42(3):244-278.
26. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139. doi:10.1136/tobaccocontrol-2012-050859.
27. Conklin DJ, Barski OA, Lesgards JF, et al. Acrolein consumption induces systemic dyslipidemia and lipoprotein modification. Toxicol Appl Pharmacol. 2010;243(1):1-12.
28. DeJarnett N, Conklin DJ, Riggs DW, et al. Acrolein exposure is associated with increased cardiovascular disease risk. J Am Heart Assoc. 2014;3:e000934.
29. Abplanalp W, DeJarnett N, Riggs D, et al. Benzene exposure is associated with increased CVD risk, hyperlipidemia, and decreased circulating angiogenic cells in humans and mice. Circulation. 2016;134(suppl-1):A14471-A14471.
30. Ran J, Qiu H, Sun S, Yang A, Tian L. Are ambient volatile organic compounds environmental stressors for heart failure? Environ Pollut. 2018;242(pt B):1810-1816.
31. Henning RJ, Johnson GT, Coyle JP, Harbison RD. Acrolein can cause cardiovascular disease: a review. Cardiovasc Toxicol. 2017;17(3):227-236.
32. Brunekreef B, Holgate ST. Air pollution and health. Lancet. 2002;360(9341):1233-1242.
33. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;23 (suppl 2):ii11-ii17.
34. Etter JF, Bullen C, Flouris AD, Laugesen M, Eissenberg T. Electronic nicotine delivery systems: a research agenda. Tob Control. 2011;20(3):243-248.
35. Hua M, Yip H, Talbot P. Mining data on usage of electronic nicotine delivery systems (ENDS) from YouTube videos. Tob Control. 2013;22(2):103-106. doi:10.1136/tobaccocontrol-2011-050226.
36. Bekki K, Uchiyama S, Ohta K, Inaba Y, Nakagome H, Kunugita N. Carbonyl compounds generated from electronic cigarettes. Int J Environ Res Public Health. 2014;11(11):11192-11200.
37. Lee YO, Hebert CJ, Nonnemaker JM, Kim AE. Multiple tobacco product use among adults in the United States: cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus. Prev Med. 2014;62:14-19.
38. King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and everuse of electronic cigarettes among U.S. adults, 2010-2011. Nicotine Tob Res. 2013;15(9):1623-1627.
39. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. e-Cigarette awareness, use, and harm perceptions in US adults. Am J Public Health. 2012;102(9):1758-1766.
40. Grana RA, Popova L, Ling PM. A longitudinal analysis of e-cigarette use and smoking cessation. JAMA Intern Med. 2014;174(5):812-813.
41. Mirbolouk M, Charkhchi P, Kianoush S, et al. Prevalence and distribution of E-cigarette use among U.S. adults: behavioral risk factor surveillance system, 2016. Ann Intern Med. 2018;169(7):429-438.
42. Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax. 2002;57(11):967-972.
43. Health UDo and Services H. A report of the surgeon general: How tobacco smoke causes disease: What it means to you. http://www.cdc.gov/ tobacco/data-statistics/sgr/2010/consumer-booklet/pdfs/consumer.pdf. 2010. Accessed October 7, 2018.
44. Giovenco DP, Lewis MJ, Delnevo CD. Factors associated with e-cigarette use: a national population survey of current and former smokers. Am J Prev Med. 2014;47(4):476-480.
45. Wills TA, Knight R, Williams RJ, Pagano I, Sargent JD. Risk factors for exclusive e-cigarette use and dual e-cigarette use and tobacco use in adolescents. Pediatrics. 2015;135(1):e43-e51.
46. Pepper JK, Brewer NT. Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review. Tob Control. 2014;23(5):375-384.
47. Burstyn I. Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health. 2014;14:18.
48. Uchiyama S, Ohta K, Inaba Y, Kunugita N. Determination of carbonyl compounds generated from the E-cigarette using coupled silica cartridges impregnated with hydroquinone and 2,4-dinitrophenylhydrazine, followed by high-performance liquid chromatography. Anal Sci. 2013;29(12):1219-1222.
49. Carnevale R, Sciarretta S, Violi F, et al. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest. 2016;150(3):606-612.
50. Coleman BN, Rostron B, Johnson SE, et al. Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) study, 2013-2014. Tob Control. 2017;26(e2): e117-e126.